Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction. - Wikidata - awgldk - TriplyDB

Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.

Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.

http://www.wikidata.org/entity/Q37445888

about

Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.

http://www.wikidata.org/entity/Q37445888

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enoxaparin in patients with pr ...... evation myocardial infarction.

@en

Enoxaparin in patients with pr ...... evation myocardial infarction.

@nl

type

label

Enoxaparin in patients with pr ...... evation myocardial infarction.

@en

Enoxaparin in patients with pr ...... evation myocardial infarction.

@nl

prefLabel

Enoxaparin in patients with pr ...... evation myocardial infarction.

@en

Enoxaparin in patients with pr ...... evation myocardial infarction.

@nl

P1433

Q37445888-3309A40B-2DA7-484C-B4D9-4B7F97C1E5DA

P1476

Q37445888-0843F08D-8495-42CE-B6F6-0EB0BBE7CAEE

P2093

Q37445888-AA2E2AE9-D232-4AE0-86A8-035F63A3A8DA

Q37445888-BF319394-7402-419A-BA50-D064D630A942

P2860

Q37445888-07FBFC15-C5B6-4F08-A784-6D8B33A668D8

Q37445888-0EC404B3-0E17-4B99-9870-E6C4A10CC4F5

Q37445888-1488017A-018B-4795-BC5B-A91B75FF6582

Q37445888-248F7A1D-D4BF-485E-B1AC-3DE8094902D0

Q37445888-2BA50196-2173-4094-B9E4-244D7AB74F82

Q37445888-2D792545-B268-44DE-A9CA-0C77C5D34370

Q37445888-31D6D778-0D7D-4C6C-AB69-3A0C0ED7532D

Q37445888-374AE2D1-B0D3-4236-A58B-FE3F1813C812

Q37445888-3DC1A532-B138-473D-B79E-AC4ECDBD716A

Q37445888-4D9CC9DF-92DD-464A-A703-46002C66C311

P304

Q37445888-45B8B3BA-69DE-49D3-8F79-88D93E7E1546

P31

Q37445888-35B6A5AB-BDC2-407F-8AD2-2E6CBB84D32C

P356

Q37445888-E66B2F54-C700-4EF8-93A8-5243B7D9A4CF

P433

Q37445888-C7EDEA75-2321-4877-99E3-0B4566CFEBEA

P478

Q37445888-814E8B20-7FDB-40B6-B461-FFBE9F923B9C

P577

Q37445888-63B934A8-C493-432A-BB7A-C56E817D3102

P698

Q37445888-BDF580BE-E937-416C-BEAC-FE5A12C9E700

P921

Q37445888-2F6DBCEB-258A-4D8B-92B0-D16166E2ADC8

P356

14796678.5.1.43

P1433

Future Cardiology

P1476

Enoxaparin in patients with pr ...... evation myocardial infarction.

@en

P2093

Arne Kristian Schwarz

http://www.w3.org/2001/XMLSchema#string

Uwe Zeymer

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Bivalirudin during primary PCI in acute myocardial infarction

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

P304

43-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796678.5.1.43

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19371202

http://www.w3.org/2001/XMLSchema#string

P921